[Federal Register Volume 65, Number 245 (Wednesday, December 20, 2000)]
[Notices]
[Pages 79870-79871]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-32358]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial

[[Page 79871]]

property such as patentable material, and personal information 
concerning individuals associated with the contract proposals, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel Human Papillomavirus Type 16 Vaccine Trial in Costa Rica.
    Date: January 8, 2001.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute, 6130 Executive Boulevard, 
Conference Room F, Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Lalita D. Palekar, PhD, Scientific Review 
Administrator, Special Review, Referral and Resources Branch, 
Division of Extramural Activities, National Cancer Institute, 
National Institutes of Health, 6116 Executive Boulevard, Room 8066, 
Bethesda, MD 20892-7405, (301) 496-7575.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)
    Dated: December 13, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-32358 Filed 12-19-00; 8:45 am]
BILLING CODE 4140-01-M